Farrow Jeffrey S
SEC CIK 1405253 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | See Remarks | 56.8K | — | $2.33M | 10 | 2024-06-17 | 2026-06-16 |
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.18M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-17 16:17 | 2026-06-15 | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | M - OptEx | — | +27.9K | 71.2K | +64% | — |
| D | 2026-06-17 16:17 | 2026-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | S - Sale+OE | $60.95 | -14.4K | 56.8K | -20% | -$877.4K |
| M | 2026-03-19 | 2026-03-17+ | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | S - Sale | $68.36 | -6,430 | 45.5K | -12% | -$439.6K |
| D | 2026-03-17 | 2026-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | M - OptEx | — | +13.0K | 49.7K | +36% | — |
| D | 2025-06-18 | 2025-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | M - OptEx | — | +27.9K | 50.3K | +124% | — |
| D | 2025-06-18 | 2025-06-17 | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | S - Sale+OE | $40.42 | -13.6K | 36.7K | -27% | -$550.0K |
| M | 2025-03-20 | 2025-03-18+ | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | S - Sale | $47.88 | -3,724 | 22.4K | -14% | -$178.3K |
| D | 2025-03-18 | 2025-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | M - OptEx | — | +8,019 | 26.2K | +44% | — |
| D | 2024-06-20 | 2024-06-17 | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | M - OptEx | — | +27.9K | 28.6K | +3,983% | — |
| D | 2024-06-20 | 2024-06-18 | TARS | Tarsus Pharmaceuticals, Inc. | Farrow Jeffrey S | See Remarks | S - Sale+OE | $27.47 | -10.4K | 18.1K | -37% | -$286.9K |
Purchase Sale Sale after option exercise All abbreviations